agilon health Q4 net loss $189M, revenue $1.57B; 2026 guidance Adj EBITDA breakeven

agilon health, inc.

Q4 net loss $189M vs $106M loss YoY; FY net loss $391M vs $260M loss.
Medical margin Q4 negative $74M vs positive $1M YoY; FY negative $57M vs positive $205M.
Adjusted EBITDA Q4 loss $142M vs $84M; FY loss $296M vs $154M.
Membership 625k (-5% YoY) from market exits; MA members 511k, ACO 114k.
2026 guidance: revenue $5.41-5.58B, Adj EBITDA ($15M)-$15M midpoint breakeven.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.